A population-based case-control teratological study of oral nystatin treatment during pregnancy

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The aim of the study was to investigate the teratogenicity of oral nystatin treatment during pregnancy in the population-based data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities between 1980 and 1996. In total, 38,151 pregnant women who delivered newborn infants without any defects (control group) and 22,843 pregnant women who had foetuses or newborns with congenital abnormalities (CA) (case group) were included in the study. 106 (0.5%) case and 143 (0.4%) control pregnant women were treated with oral nystatin (crude OR with 95% CI = 1.2, 1.0-1.6). A teratogenic potential of nystatin was seen in 1 CA-group (hypospadias) in 2 different approaches of the study (case-control and total control - CA groups comparison) during the critical period of this congenital abnormality. The conclusion of the study is that treatment with oral nystatin during pregnancy presents little teratogenic risk to the foetus, but the possible association between hypospadias and nystatin needs further study.

Original languageEnglish
Pages (from-to)830-835
Number of pages6
JournalScandinavian Journal of Infectious Diseases
Volume35
Issue number11-12
DOIs
Publication statusPublished - Dec 1 2003

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'A population-based case-control teratological study of oral nystatin treatment during pregnancy'. Together they form a unique fingerprint.

  • Cite this